Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits

MLA

Mario Schiavoni, et al. “Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits.” Frontiers in Medicine, vol. 6, Dec. 2019. EBSCOhost, https://doi.org/10.3389/fmed.2019.00261.

APA

Mario Schiavoni, Mariasanta Napolitano, Gaetano Giuffrida, Antonella Coluccia, Sergio Siragusa, Valeria Calafiore, Giuseppe Lassandro, & Paola Giordano. (2019). Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits. Frontiers in Medicine, 6. https://doi.org/10.3389/fmed.2019.00261

Chicago

Mario Schiavoni, Mariasanta Napolitano, Gaetano Giuffrida, Antonella Coluccia, Sergio Siragusa, Valeria Calafiore, Giuseppe Lassandro, and Paola Giordano. 2019. “Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits.” Frontiers in Medicine 6 (December). doi:10.3389/fmed.2019.00261.